Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Ireland CDMO Directory · Waterford, Co. Waterford

EirGen Pharma

High-Potency OSD & Oncology

160+
Employees
40,000 sq ft (+3,500m² expansion, ~77,700 sq ft total)
Facility
Waterford
County
4
Certifications

Facility Overview

Specializes in high-potency oral solid dose medicines for oncology and rare diseases. Produces 520M dosage units annually across 60 countries, targeting 1B units/yr by 2027.

High-containment oncology leader (Targeting 1B units/yr by 2027)

Capabilities

High-Potency OSD Oncology Softgel Capsules Rare Diseases Film-Coated Tablets

Certifications & Regulatory Licenses

FDA Approved EMA (EU GMP) HPRA Licensed ISO Certified
Sourcing & Facility Audit

Considering EirGen Pharma for your shortlist?

Tell us your molecule type, dosage form, batch size, and target markets. We coordinate a direct introduction and independent facility assessment.

Request Sourcing & Audit →